BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 44 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,228,000 | -6.7% | 3,800,000 | +0.5% | 0.01% | +22.2% |
| Q3 2018 | $4,534,000 | +4.0% | 3,780,000 | +2.7% | 0.01% | 0.0% |
| Q2 2018 | $4,361,000 | +25.9% | 3,681,000 | +17.0% | 0.01% | +12.5% |
| Q1 2018 | $3,464,000 | -15.9% | 3,145,000 | -9.6% | 0.01% | -11.1% |
| Q4 2017 | $4,119,000 | +3.2% | 3,478,000 | +4.3% | 0.01% | 0.0% |
| Q3 2017 | $3,992,000 | +0.4% | 3,335,000 | -0.3% | 0.01% | 0.0% |
| Q2 2017 | $3,977,000 | +0.6% | 3,344,000 | -0.1% | 0.01% | 0.0% |
| Q1 2017 | $3,952,000 | +1.9% | 3,347,000 | +1.1% | 0.01% | -10.0% |
| Q4 2016 | $3,880,000 | -6.9% | 3,311,000 | -1.0% | 0.01% | -16.7% |
| Q3 2016 | $4,168,000 | +8.5% | 3,343,000 | +0.6% | 0.01% | -20.0% |
| Q2 2016 | $3,841,000 | +90.7% | 3,322,000 | +95.5% | 0.02% | +87.5% |
| Q1 2016 | $2,014,000 | +40180.0% | 1,699,000 | +42375.0% | 0.01% | – |
| Q3 2014 | $5,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|